Epdox-CV 325 from Aingo Pharma is a potent combination of Cefpodoxime Proxetil (200 mg) and Potassium Clavulanate (125 mg), engineered to combat a wide range of bacterial infections. Cefpodoxime, a third-generation cephalosporin, is effective against both Gram-positive and Gram-negative bacteria. When paired with Clavulanate, a beta-lactamase inhibitor, its effectiveness is significantly enhanced, overcoming resistance by breaking down bacterial defense mechanisms.
Indicated for conditions like respiratory tract infections, skin infections, and urinary tract infections, Epdox-CV 325 is available in a 10×10 tablet pack. The synergy between the ingredients ensures fast-acting and broad-spectrum antibacterial protection. Ideal for prescription use in clinics and hospitals, this formulation ensures high compliance and efficacy.
